SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-041772
Filing Date
2019-11-07
Accepted
2019-11-07 16:21:33
Documents
66
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pfnx-10q_20190930.htm 10-Q 2342593
2 EX-31.1 pfnx-ex311_8.htm EX-31.1 17758
3 EX-31.2 pfnx-ex312_7.htm EX-31.2 17737
4 EX-32.1 pfnx-ex321_6.htm EX-32.1 9811
  Complete submission text file 0001564590-19-041772.txt   7403904

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT pfnx-20190930.xml EX-101.INS 1497749
6 XBRL TAXONOMY EXTENSION SCHEMA pfnx-20190930.xsd EX-101.SCH 49762
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pfnx-20190930_cal.xml EX-101.CAL 42161
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pfnx-20190930_def.xml EX-101.DEF 158554
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pfnx-20190930_lab.xml EX-101.LAB 408998
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pfnx-20190930_pre.xml EX-101.PRE 311253
Mailing Address 10790 ROSELLE STREET SAN DIEGO CA 92121
Business Address 10790 ROSELLE STREET SAN DIEGO CA 92121 858-352-4400
Pfenex Inc. (Filer) CIK: 0001478121 (see all company filings)

IRS No.: 271356759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36540 | Film No.: 191200675
SIC: 2834 Pharmaceutical Preparations